跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
益路取 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Tildrakizumab Injection
Approved
生物制品
Tildrakizumab Injection
SUN PHARMACEUTICAL INDUSTRIES LIMITED
🇨🇳 National Medical Products Administration
Approval Date
May 26, 2023
Approval ID
1z32dBnAJcY
Company
SUN PHARMACEUTICAL INDUSTRIES LIMITED
Type
生物制品
Approval Details
Approval Id
1z32dBnAJcY
Approval Number
国药准字SJ20230006
Generic Name
替瑞奇珠单抗注射液
Generic Name En
Tildrakizumab Injection
Trade Name
益路取
Drug Type
生物制品
Dosage Form
注射剂
Strength
100mg(1 ml)/支
Reg Date
2023-05-26
Expired Date
2028-05-25
Company Name
SUN PHARMACEUTICAL INDUSTRIES LIMITED
Production Company Name
Vetter Pharma-Fertigung GmbH & Co. KG
Company Detail Path
/organization/sun-pharmaceutical-industries-limited
Production Company Detail Path
/organization/vetter-pharma-fertigung-gmbh-and-co-kg
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
May 26, 2023
Approval ID
1z32dBnAJcY
Type
生物制品
Back to NMPA Approvals